Expecting Data From Theranos, Lab Experts Get New Product

  • Founder Holmes questioned about technology at medical meeting
  • ‘Not yet a game changer,’ panelist says of new device

Theranos Reveals Diagnostic-Testing Tech at Meeting

It was expected to be an academic presentation to show if Theranos Inc.’s controversial blood-testing technology worked, and perhaps explain the science behind the claims that the startup could do lab tests with a fraction of the blood and cost of traditional machines.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.